Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Joachim Rudolph - Principal Scientist (Chemistry), Discovery Chemistry

Joachim Rudolph

Principal Scientist (Chemistry), Discovery Chemistry

Postdoc Mentor
Years at Genentech
Awards & Honors

I joined Genentech in 2007 with 10 years of prior industry experience in the US and Germany.

I did my doctoral studies in organic chemistry at the Max-Planck Institute in Mülheim, Germany, in the group of Manfred Reetz, followed by a post-doctoral stay at The Scripps Research Institute in the laboratory of K. Barry Sharpless. My pharmaceutical industry career began in 1997 at Bayer in Germany and continued in the Bayer Pharmaceutical Research Center in West Haven, Connecticut until 2007.

Featured Publication

Leveraging the Pre-DFG Residue Thr-406 To Obtain High Kinase Selectivity in an Aminopyrazole-Type PAK1 Inhibitor Series.

ACS Med Chem Lett. 2015 May; 6(6): 711-5.

Rudolph J, Aliagas I, Crawford JJ, Mathieu S, Lee W, Chao Q, Dong P, Rouge L, Wang W, Heise C, Murray LJ, La H, Liu Y, Manning G, Diederich F, Hoeflich KP.

Phenotypic screening in cancer drug discovery - past, present and future.

Nat Rev Drug Discov. 2014 Aug; 13(8): 588-602.

Moffat JG, Rudolph J, Bailey D.